**Migraine Breakthrough:** First Oral Treatment Soon Available on the NHS to Prevent Debilitating Head Pain – Experts Say Up to 170,000 Could Benefit
London, England – A groundbreaking new oral treatment for both chronic and episodic migraines is on the horizon for residents in England. According to health experts, up to 170,000 individuals could potentially benefit from atogepant, a drug aimed at preventing severe head pain that can be debilitating. The National Institute for Health and Care Excellence (NICE) has endorsed atogepant, a tablet-based medication, for individuals who have not found success with other treatments or are unable …